Mumbai-based startup Qure.ai has appointed Dr Javier J Zulueta, previously Professor of Medicine at the Icahn School of Medicine at Mount Sinai in New York and Pulmonary Division Chief at Mount Sinai Morningside Hospital, to the new position of Chief Medical Officer, Pulmonology.
The role will dovetail his deep clinical insight to the ongoing research & development in lung health AI and digital health care coordination solutions to bolster Qure.ai’s pace of business expansion in the USA and Europe.
Dr Zulueta brings more than three decades of experience as a physician, scientist, academician and pioneer in interventional pulmonology, lung cancer screening and pulmonary nodule / disease management. Prior to Mount Sinai, he founded and led the inaugural Department of Respiratory Medicine at Clinica Universidad de Navarra in Pamplona, Spain’s premier medical school, where he launched the country’s first lung cancer screening programme as Principal Investigator of the International Early Lung Cancer Action Program (IELCAP).
His passion in the advancement of early lung cancer detection through medical technology has also led to him taking a number of past roles with commercial companies as an Advisory Board Member.
The new CMO appointment builds on a rapid pace of business scaling for Qure.ai in the USA. At the start of 2025 it appointed Jim Mercadante as Chief Commercial Officer, followed by a dozen business development, sales and strategic account management appointments across the States.
